Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

BIOMAP

Financiado

Cerrado

Simultaneous Elemental and Molecular Imaging of Biological Targets A New Parad...

Simultaneous Elemental and Molecular Imaging of Biological Targets A New Paradigm for the Study of Disease and its Treatment "This project proposes the development of a technology capable of delivering, high speed, simultaneous elemental and molecular maps of biological targets. Specifically these targets will include plaques associated with age-related... ver más

12/03/2014

LOUGHBOROUGH UNIVE...

210K€

Presupuesto del proyecto: 210K€

Líder del proyecto

LOUGHBOROUGH UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-03-12 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

LOUGHBOROUGH UNIVERSITY

0.00€ | Lider

Proyectos interesantes

PhoRAu

Medical Technol...

Applied Physics

158K€ Cerrado

DINAMIT

Medical Technol...

Nanotechnology

265K€ Cerrado

PID2021-127187OB-C22

Medical Technol...

Nanotechnology

91K€ Cerrado

PROMPT

Medical Technol...

Nanotechnology

168K€ Cerrado

NANO-PEFIS

Medical Technol...

Nanotechnology

Cerrado

KILLCANCER

Medical Technol...

Nanotechnology

2M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

LOUGHBOROUGH UNIVERSITY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 210K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "This project proposes the development of a technology capable of delivering, high speed, simultaneous elemental and molecular maps of biological targets. Specifically these targets will include plaques associated with age-related macular degeneration (AMD), tumours treated with Pt-based chemotherapy drugs, and cell populations derived from the FP7 project, the ONE Study. The dual-mode imaging system will enable the analysis of metallo-proteins and their binding sites, or where there is no native metal tag or its abundance is too small to detect, anti-body or specific reactive chemistry metal or nano-particle tags will be added to the target molecules. For the ONE Study, one of the key project aims is to develop cell labelling strategies that will enable therapeutically administered cells to be tracked at low abundance in the host cell populations without toxic impact on either the therapeutic cells or host organism. The technology will be based on employing a common pulsed laser platform for laser ablation, desorption, or matrix assisted sampling of the target material simultaneously coupled with inductively-coupled plasma elemental mass spectrometry (ICP-MS) and ion trap organic mass spectrometry. In the case of the molecular mass spectrometry, electro-spray or matrix assisted charging will be used. The sampling will employ a technology developed in the host laboratory that enables targets to be sampled at atmospheric pressure whilst excluding atmosphere from the sampling point. The technology will be optimised for high speed and high efficiency to enable rapid mapping of targets at very high sensitivity. This will require development of a new high efficiency torch design for ICP-MS and the novel use of micro-jet pumps to deliver samples to the mass spectrometers. The project will also take advantage of the Fellow’s expertise in synchrotron X-ray techniques to obtain non-destructive and comparative analyses of the specimen materials."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores